Fierce Health Payers January 10, 2022
Robert King

Biogen’s decision to halve the price of its controversial Alzheimer’s drug Aduhelm has the Biden administration rethinking the 15% hike for Part B premiums for 2022.

Department of Health and Human Services Secretary Xavier Becerra announced Monday that he wants the Centers for Medicare and Medicaid Services to reassess its proposed price hike.

“With the 50% price drop of Aduhelm on January 1, there is a compelling basis for CMS to reexamine the previous recommendation,” Becerra said in a brief statement.

CMS announced in November that premiums for Part B for 2022 will increase from $148.50 to $170.10 and annual deductibles will also rise from $203 to $233.

Part B covers a slew of physician and hospital services and reimburses...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, HHS, Insurance, Medicare
HHS Announces Medicaid and Medicare Flexibilities, Investigations post-Change Healthcare Cyberattack
Medicare, Medicaid made $100B in improper payments in 2023
Medicare’s GLP-1 spending is skyrocketing, even without weight loss coverage: KFF
Can Hospital At Home Finally Hit Its Tipping Point? Lessons From The Hospitalist Field
Is Medicare keeping pace with our aging population? Experts say 'we need to double down and go faster'

Share This Article